| 书目名称 | Reviews on New Drug Targets in Age-Related Disorders |
| 编辑 | Paul C. Guest |
| 视频video | |
| 概述 | Provides an overview of studies on age-related disorders, which is an increasing problem worldwide.Describes the research underway to slow or delay the progress of age-related diseases in humans.Discu |
| 丛书名称 | Advances in Experimental Medicine and Biology |
| 图书封面 |  |
| 描述 | .Aging is an inevitable part of life and is becoming a worldwide social, economic and health problem. This is mainly due to the fact that the increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders, such as type II diabetes mellitus, cardiovascular disorders, sarcopenia, and neurodegenerative conditions. New therapeutic approaches are still needed to decrease or slow the effects of such diseases. Advances in -omic technologies, such as genomics, transcriptomics, proteomics and metabolomics, have significantly advanced our understanding of disease in multiple medical areas, as the analysis of multiple molecular networks has simultaneously provided a more integrated view of disease pathways. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan. In turn, this will lead to new therapeutic strategies as well as drug development projects by the pharmaceutical industry...This book presents a series of reviews describing studies that have resulted in identification of new potential drug |
| 出版日期 | Book 2020 |
| 关键词 | age-related diseases; parabiosis; bioactive lipids; Alzheimer’s disease; Metformin; Proteomics; Metabolomi |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-030-42667-5 |
| isbn_softcover | 978-3-030-42669-9 |
| isbn_ebook | 978-3-030-42667-5Series ISSN 0065-2598 Series E-ISSN 2214-8019 |
| issn_series | 0065-2598 |
| copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
发表于 2025-3-21 19:05:23
